Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Mar;87(3):977–985. doi: 10.1172/JCI115106

Evidence that tumor necrosis factor plays a pathogenetic role in the paraneoplastic syndromes of cachexia, hypercalcemia, and leukocytosis in a human tumor in nude mice.

T Yoneda 1, M A Alsina 1, J B Chavez 1, L Bonewald 1, R Nishimura 1, G R Mundy 1
PMCID: PMC329890  PMID: 1999505

Abstract

Recently, we have established a human squamous cell carcinoma of the maxilla (called MH-85) associated with hypercalcemia, leukocytosis, and cachexia in culture. MH-85 tumor cells caused the same paraneoplastic syndromes in tumor-bearing nude mice. We found that there was a sixfold increase in splenic size in MH-85 tumor-bearing mice. This increase paralleled tumor growth and was reversed by surgical removal of the tumor. Splenectomy in nude mice 1 wk before or 6 wk after tumor inoculation resulted in a decrease in tumor growth, and impairment of hypercalcemia, leukocytosis, and cachexia. In MH-85 tumor-bearing animals that had been pretreated by splenectomy, intravenous injection of fresh normal spleen cells caused an immediate reversal of leukocytosis, hypercalcemia, and cachexia. Since the presence of cachexia in both the patient and the mice carrying the tumor suggested tumor necrosis factor (TNF) may be overproduced, we injected polyclonal neutralizing antibodies raised against murine TNF into tumor-bearing mice. There was a rapid and reproducible decrease in blood ionized calcium, accompanied by suppression of osteoclast activity. No changes in blood ionized calcium were seen in mice injected with normal immune sera. In addition, there was an increase in body weight and decrease in white cell count. Plasma immunoreactive TNF was increased almost fourfold in tumor-bearing nude mice compared with control nude mice. Although TNF activity was undetectable in MH-85 culture supernatants, cells of the macrophage lineage, including spleen cells, released increased amounts of TNF when cultured with MH-85 tumor-conditioned media. These results suggest that splenic cytokines such as TNF may influence the development of the paraneoplastic syndromes of hypercalcemia, leukocytosis, and cachexia in these animals, as well as tumor growth. They also show that paraneoplastic syndromes may be due to factors produced by normal host cells stimulated by the presence of the tumor.

Full text

PDF
977

Images in this article

982Image
on p.982

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abeloff M. D. Paraneoplastic syndromes: a window on the biology of cancer. N Engl J Med. 1987 Dec 17;317(25):1598–1600. doi: 10.1056/NEJM198712173172509. [DOI] [PubMed] [Google Scholar]
  2. Aggarwal B. B., Kohr W. J., Hass P. E., Moffat B., Spencer S. A., Henzel W. J., Bringman T. S., Nedwin G. E., Goeddel D. V., Harkins R. N. Human tumor necrosis factor. Production, purification, and characterization. J Biol Chem. 1985 Feb 25;260(4):2345–2354. [PubMed] [Google Scholar]
  3. Almawi W. Y., Dolphin P. J., Thies R. L., McMaster W. R., Levy J. G., Pope B. L. Suppressor cell-inducing factor: a new lymphokine secreted by a natural suppressor cell line with natural cytotoxic activity. I. Purification to apparent homogeneity and initial characterization of suppressor cell-inducing factor. J Immunol. 1988 Oct 15;141(8):2529–2535. [PubMed] [Google Scholar]
  4. Berchtold P., McMillan R. Therapy of chronic idiopathic thrombocytopenic purpura in adults. Blood. 1989 Nov 15;74(7):2309–2317. [PubMed] [Google Scholar]
  5. Beutler B., Cerami A. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem. 1988;57:505–518. doi: 10.1146/annurev.bi.57.070188.002445. [DOI] [PubMed] [Google Scholar]
  6. Cannistra S. A., Rambaldi A., Spriggs D. R., Herrmann F., Kufe D., Griffin J. D. Human granulocyte-macrophage colony-stimulating factor induces expression of the tumor necrosis factor gene by the U937 cell line and by normal human monocytes. J Clin Invest. 1987 Jun;79(6):1720–1728. doi: 10.1172/JCI113012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Carswell E. A., Old L. J., Kassel R. L., Green S., Fiore N., Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3666–3670. doi: 10.1073/pnas.72.9.3666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Collins S. J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood. 1987 Nov;70(5):1233–1244. [PubMed] [Google Scholar]
  9. Donahue R. E., Wang E. A., Stone D. K., Kamen R., Wong G. G., Sehgal P. K., Nathan D. G., Clark S. C. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. 1986 Jun 26-Jul 2Nature. 321(6073):872–875. doi: 10.1038/321872a0. [DOI] [PubMed] [Google Scholar]
  10. Frindel E., Malaise E. P., Alpen E., Tubiana M. Kinetics of cell proliferation of an experimental tumor. Cancer Res. 1967 Jun;27(6):1122–1131. [PubMed] [Google Scholar]
  11. Fu Y. X., Watson G., Jimenez J. J., Wang Y., Lopez D. M. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Cancer Res. 1990 Jan 15;50(2):227–234. [PubMed] [Google Scholar]
  12. Fujii T., Igarashi T., Kishimoto S. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice. J Natl Cancer Inst. 1987 Mar;78(3):509–517. [PubMed] [Google Scholar]
  13. Groopman J. E., Mitsuyasu R. T., DeLeo M. J., Oette D. H., Golde D. W. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on myelopoiesis in the acquired immunodeficiency syndrome. N Engl J Med. 1987 Sep 3;317(10):593–598. doi: 10.1056/NEJM198709033171003. [DOI] [PubMed] [Google Scholar]
  14. Hardy C. L., Balducci L. Hemopoietic alterations of cancer. Am J Med Sci. 1985 Nov;290(5):196–205. doi: 10.1097/00000441-198511000-00004. [DOI] [PubMed] [Google Scholar]
  15. Heidenreich S., Gong J. H., Schmidt A., Nain M., Gemsa D. Macrophage activation by granulocyte/macrophage colony-stimulating factor. Priming for enhanced release of tumor necrosis factor-alpha and prostaglandin E2. J Immunol. 1989 Aug 15;143(4):1198–1205. [PubMed] [Google Scholar]
  16. Ishikawa M., Hosokawa M., Oh-hara N., Niho Y., Kobayashi H. Marked granulocytosis in C57BL/6 mice bearing a transplanted BMT-11 fibrosarcoma. J Natl Cancer Inst. 1987 Mar;78(3):567–571. [PubMed] [Google Scholar]
  17. JENSEN F. C., GWATKIN R. B., BIGGERS J. D. A SIMPLE ORGAN CULTURE METHOD WHICH ALLOWS SIMULTANEOUS ISOLATION OF SPECIFIC TYPES OF CELLS. Exp Cell Res. 1964 May;34:440–447. doi: 10.1016/0014-4827(64)90231-9. [DOI] [PubMed] [Google Scholar]
  18. Jacobs D. M., Morrison D. C. Inhibition of the mitogenic response to lipopolysaccharide (LPS) in mouse spleen cells by polymyxin B. J Immunol. 1977 Jan;118(1):21–27. [PubMed] [Google Scholar]
  19. Johnson R. A., Boyce B. F., Mundy G. R., Roodman G. D. Tumors producing human tumor necrosis factor induced hypercalcemia and osteoclastic bone resorption in nude mice. Endocrinology. 1989 Mar;124(3):1424–1427. doi: 10.1210/endo-124-3-1424. [DOI] [PubMed] [Google Scholar]
  20. Kawakami M., Pekala P. H., Lane M. D., Cerami A. Lipoprotein lipase suppression in 3T3-L1 cells by an endotoxin-induced mediator from exudate cells. Proc Natl Acad Sci U S A. 1982 Feb;79(3):912–916. doi: 10.1073/pnas.79.3.912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kirchner H., Chused T. M., Herberman R. B., Holden H. T., Lavrin D. H. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus. J Exp Med. 1974 Jun 1;139(6):1473–1487. doi: 10.1084/jem.139.6.1473. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kondo Y., Sato K., Ohkawa H., Ueyama Y., Okabe T., Sato N., Asano S., Mori M., Ohsawa N., Kosaka K. Association of hypercalcemia with tumors producing colony-stimulating factor(s). Cancer Res. 1983 May;43(5):2368–2374. [PubMed] [Google Scholar]
  23. König A., Mühlbauer R. C., Fleisch H. Tumor necrosis factor alpha and interleukin-1 stimulate bone resorption in vivo as measured by urinary [3H]tetracycline excretion from prelabeled mice. J Bone Miner Res. 1988 Dec;3(6):621–627. doi: 10.1002/jbmr.5650030607. [DOI] [PubMed] [Google Scholar]
  24. LAPPAT E. J., CAWEIN M. A STUDY OF THE LEUKEMOID RESPONSE TO TRANSPLANTABLE A-280 TUMOR IN MICE. Cancer Res. 1964 Feb;24:302–311. [PubMed] [Google Scholar]
  25. Le J., Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest. 1987 Mar;56(3):234–248. [PubMed] [Google Scholar]
  26. Lee M. Y., Liu C. C., Lottsfeldt J. L., Judkins S. A., Howard G. A. Production of granulocyte-stimulating and bone cell-modulating activities from a neutrophilia hypercalcemia-inducing murine mammary cancer cell line. Cancer Res. 1987 Aug 1;47(15):4059–4065. [PubMed] [Google Scholar]
  27. Lindemann A., Ludwig W. D., Oster W., Mertelsmann R., Herrmann F. High-level secretion of tumor necrosis factor-alpha contributes to hematopoietic failure in hairy cell leukemia. Blood. 1989 Mar;73(4):880–884. [PubMed] [Google Scholar]
  28. Lindemann A., Riedel D., Oster W., Mertelsmann R., Herrmann F. Recombinant human granulocyte-macrophage colony-stimulating factor induces secretion of autoinhibitory monokines by U-937 cells. Eur J Immunol. 1988 Mar;18(3):369–374. doi: 10.1002/eji.1830180308. [DOI] [PubMed] [Google Scholar]
  29. Moldawer L. L., Gelin J., Scherstén T., Lundholm K. G. Circulating interleukin 1 and tumor necrosis factor during inflammation. Am J Physiol. 1987 Dec;253(6 Pt 2):R922–R928. doi: 10.1152/ajpregu.1987.253.6.R922. [DOI] [PubMed] [Google Scholar]
  30. Moldawer L. L., Lowry S. F., Cerami A. Cachectin: its impact on metabolism and nutritional status. Annu Rev Nutr. 1988;8:585–609. doi: 10.1146/annurev.nu.08.070188.003101. [DOI] [PubMed] [Google Scholar]
  31. Mundy G. R., Ibbotson K. J., D'Souza S. M. Tumor products and the hypercalcemia of malignancy. J Clin Invest. 1985 Aug;76(2):391–394. doi: 10.1172/JCI111984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Mundy G. R., Martin T. J. The hypercalcemia of malignancy: pathogenesis and management. Metabolism. 1982 Dec;31(12):1247–1277. doi: 10.1016/0026-0495(82)90012-9. [DOI] [PubMed] [Google Scholar]
  33. Nelson D. S., Nelson M. Evasion of host defences by tumours. Immunol Cell Biol. 1987 Aug;65(Pt 4):287–304. doi: 10.1038/icb.1987.33. [DOI] [PubMed] [Google Scholar]
  34. Norton J. A., Peacock J. L., Morrison S. D. Cancer cachexia. Crit Rev Oncol Hematol. 1987;7(4):289–327. doi: 10.1016/s1040-8428(87)80003-3. [DOI] [PubMed] [Google Scholar]
  35. Old L. J. Tumor necrosis factor. Sci Am. 1988 May;258(5):59-60, 69-75. doi: 10.1038/scientificamerican0588-59. [DOI] [PubMed] [Google Scholar]
  36. Oliff A., Defeo-Jones D., Boyer M., Martinez D., Kiefer D., Vuocolo G., Wolfe A., Socher S. H. Tumors secreting human TNF/cachectin induce cachexia in mice. Cell. 1987 Aug 14;50(4):555–563. doi: 10.1016/0092-8674(87)90028-6. [DOI] [PubMed] [Google Scholar]
  37. Pfeilschifter J., Chenu C., Bird A., Mundy G. R., Roodman G. D. Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro. J Bone Miner Res. 1989 Feb;4(1):113–118. doi: 10.1002/jbmr.5650040116. [DOI] [PubMed] [Google Scholar]
  38. Remick D. G., Larrick J., Kunkel S. L. Tumor necrosis factor-induced alterations in circulating leukocyte populations. Biochem Biophys Res Commun. 1986 Dec 15;141(2):818–824. doi: 10.1016/s0006-291x(86)80246-7. [DOI] [PubMed] [Google Scholar]
  39. Rosove M. H., Naeim F., Harwig S., Zighelboim J. Severe platelet dysfunction in hairy cell leukemia with improvement after splenectomy. Blood. 1980 Jun;55(6):903–906. [PubMed] [Google Scholar]
  40. Sabatini M., Boyce B., Aufdemorte T., Bonewald L., Mundy G. R. Infusions of recombinant human interleukins 1 alpha and 1 beta cause hypercalcemia in normal mice. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5235–5239. doi: 10.1073/pnas.85.14.5235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Sabatini M., Chavez J., Mundy G. R., Bonewald L. F. Stimulation of tumor necrosis factor release from monocytic cells by the A375 human melanoma via granulocyte-macrophage colony-stimulating factor. Cancer Res. 1990 May 1;50(9):2673–2678. [PubMed] [Google Scholar]
  42. Saito K., Kuratomi Y., Yamamoto K., Saito T., Kuzuya T., Yoshida S., Moriyama S. I., Takahashi A. Primary squamous cell carcinoma of the thyroid associated with marked leukocytosis and hypercalcemia. Cancer. 1981 Nov 1;48(9):2080–2083. doi: 10.1002/1097-0142(19811101)48:9<2080::aid-cncr2820480927>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  43. Sato K., Mimura H., Han D. C., Kakiuchi T., Ueyama Y., Ohkawa H., Okabe T., Kondo Y., Ohsawa N., Tsushima T. Production of bone-resorbing activity and colony-stimulating activity in vivo and in vitro by a human squamous cell carcinoma associated with hypercalcemia and leukocytosis. J Clin Invest. 1986 Jul;78(1):145–154. doi: 10.1172/JCI112544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Sato N., Asano S., Ueyama Y., Mori M., Okabe T., Kondo Y., Ohsawa N., Kosaka K. Granulocytosis and colony-stimulating activity (CSA) produced by a human squamous cell carcinoma. Cancer. 1979 Feb;43(2):605–610. doi: 10.1002/1097-0142(197902)43:2<605::aid-cncr2820430230>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  45. Scadden D. T., Zon L. I., Groopman J. E. Pathophysiology and management of HIV-associated hematologic disorders. Blood. 1989 Oct;74(5):1455–1463. [PubMed] [Google Scholar]
  46. Shoenfeld Y., Tal A., Berliner S., Pinkhas J. Leukocytosis in non hematological malignancies--a possible tumor-associated marker. J Cancer Res Clin Oncol. 1986;111(1):54–58. doi: 10.1007/BF00402777. [DOI] [PubMed] [Google Scholar]
  47. Sisson S. D., Dinarello C. A. Production of interleukin-1 alpha, interleukin-1 beta and tumor necrosis factor by human mononuclear cells stimulated with granulocyte-macrophage colony-stimulating factor. Blood. 1988 Oct;72(4):1368–1374. [PubMed] [Google Scholar]
  48. Socher S. H., Martinez D., Craig J. B., Kuhn J. G., Oliff A. Tumor necrosis factor not detectable in patients with clinical cancer cachexia. J Natl Cancer Inst. 1988 Jun 15;80(8):595–598. doi: 10.1093/jnci/80.8.595. [DOI] [PubMed] [Google Scholar]
  49. Sundström C., Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer. 1976 May 15;17(5):565–577. doi: 10.1002/ijc.2910170504. [DOI] [PubMed] [Google Scholar]
  50. Tashjian A. H., Jr, Voelkel E. F., Lazzaro M., Goad D., Bosma T., Levine L. Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology. 1987 May;120(5):2029–2036. doi: 10.1210/endo-120-5-2029. [DOI] [PubMed] [Google Scholar]
  51. Ulich T. R., del Castillo J., Keys M., Granger G. A., Ni R. X. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol. 1987 Nov 15;139(10):3406–3415. [PubMed] [Google Scholar]
  52. Williams D. M., Bonewald L. F., Roodman G. D., Byrne G. I., Magee D. M., Schachter J. Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection. Infect Immun. 1989 May;57(5):1351–1355. doi: 10.1128/iai.57.5.1351-1355.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Wing E. J., Magee D. M., Whiteside T. L., Kaplan S. S., Shadduck R. K. Recombinant human granulocyte/macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor alpha and interferon in cancer patients. Blood. 1989 Feb 15;73(3):643–646. [PubMed] [Google Scholar]
  54. Yates A. J., Gutierrez G. E., Smolens P., Travis P. S., Katz M. S., Aufdemorte T. B., Boyce B. F., Hymer T. K., Poser J. W., Mundy G. R. Effects of a synthetic peptide of a parathyroid hormone-related protein on calcium homeostasis, renal tubular calcium reabsorption, and bone metabolism in vivo and in vitro in rodents. J Clin Invest. 1988 Mar;81(3):932–938. doi: 10.1172/JCI113406. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES